Combined Ruxolitinib and Venetoclax Treatment in a Patient with a BCR-JAK2 Rearranged Myeloid Neoplasm

por Lap, Coen J., Nassereddine, Samah, Liu, Min-Ling, Nava, Victor E., Aggarwal, Anita
Publicado 2021

Plasmablastic Lymphoma: Case Report of Prolonged Survival of an Advanced Human Immunodeficiency Patient and Literature Review

por Rafei, Hind, El-Bahesh, Ehab, Finianos, Antoine, Liu, Min-Ling L., Schechter, Geraldine P.
Publicado 2017

Refractory Splenic Marginal Zone Lymphoma Responsive to Combination Venetoclax and Bortezomib (Velcade) (V(2)) Therapy

por Roche, Kyle C., DeRosa, Peter A., Liu, Min-Ling, Nava, Victor E., Aggarwal, Anita
Publicado 2022

Concurrent Waldenstrom’s Macroglobulinemia and Myelodysplastic Syndrome with a Sequent t(10;13)(p13;q22) Translocation

por DeRosa, Peter A., Roche, Kyle C., Nava, Victor E., Singh, Sunita, Liu, Min-Ling, Agarwal, Anita
Publicado 2022

Tumor-Infiltrating Immune Cells: Triggers for Tumor Capsule Disruption and Tumor Progression?

por Jiang, Bin, Mason, Jeffrey, Jewett, Anahid, Liu, Min-ling, Chen, Wen, Qian, Jun, Ding, Yijiang, Ding, Shuqing, Ni, Min, Zhang, Xichen, Man, Yan-gao
Publicado 2013

TMSB4Y is a candidate tumor suppressor on the Y chromosome and is deleted in male breast cancer

por Wong, Hong Yuen, Wang, Grace M., Croessmann, Sarah, Zabransky, Daniel J., Chu, David, Garay, Joseph P., Cidado, Justin, Cochran, Rory L., Beaver, Julia A., Aggarwal, Anita, Liu, Min-Ling, Argani, Pedram, Meeker, Alan, Hurley, Paula J., Lauring, Josh, Park, Ben Ho
Publicado 2015